{"id":321,"date":"2024-09-25T12:04:51","date_gmt":"2024-09-25T12:04:51","guid":{"rendered":"https:\/\/sites.exeter.ac.uk\/age\/?page_id=321"},"modified":"2024-09-25T12:04:52","modified_gmt":"2024-09-25T12:04:52","slug":"pharmacogenetics","status":"publish","type":"page","link":"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/","title":{"rendered":"Pharmacogenetics"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Pharmacogenetics in cardiovascular prevention<\/h2>\n\n\n\n<p>Inherited genetic variants can modify the effectiveness of medications, and contribute to inter-individual variability and susceptibility to side-effects. We provide much-needed observational evidence for the effect of pharmacogenetic variants on commonly-prescribed preventative medications for cardiovascular disease, especially statins (prescribed to reduce cholesterol), antihypertensives (prescribed to reduce blood pressure), and antiplatelets (prescribed to reduce the risk of strokes and heart attacks caused by blood clots).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmacogenetics in cardiovascular prevention Inherited genetic variants can modify the effectiveness of medications, and contribute to inter-individual variability and susceptibility to side-effects. We provide much-needed observational evidence for the effect of pharmacogenetic variants on commonly-prescribed preventative medications for cardiovascular disease, especially statins (prescribed to reduce cholesterol), antihypertensives (prescribed to reduce blood pressure), and antiplatelets (prescribed [&hellip;]<\/p>\n","protected":false},"author":293,"featured_media":0,"parent":159,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharmacogenetics - AGE @ Exeter<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacogenetics - AGE @ Exeter\" \/>\n<meta property=\"og:description\" content=\"Pharmacogenetics in cardiovascular prevention Inherited genetic variants can modify the effectiveness of medications, and contribute to inter-individual variability and susceptibility to side-effects. We provide much-needed observational evidence for the effect of pharmacogenetic variants on commonly-prescribed preventative medications for cardiovascular disease, especially statins (prescribed to reduce cholesterol), antihypertensives (prescribed to reduce blood pressure), and antiplatelets (prescribed [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/\" \/>\n<meta property=\"og:site_name\" content=\"AGE @ Exeter\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-25T12:04:52+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/\",\"url\":\"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/\",\"name\":\"Pharmacogenetics - AGE @ Exeter\",\"isPartOf\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/age\/#website\"},\"datePublished\":\"2024-09-25T12:04:51+00:00\",\"dateModified\":\"2024-09-25T12:04:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sites.exeter.ac.uk\/age\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research\",\"item\":\"https:\/\/sites.exeter.ac.uk\/age\/research\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pharmacogenetics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/age\/#website\",\"url\":\"https:\/\/sites.exeter.ac.uk\/age\/\",\"name\":\"AGE @ Exeter\",\"description\":\"Ageing and long-term conditions, Genetics, and Epidemiology group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sites.exeter.ac.uk\/age\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacogenetics - AGE @ Exeter","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacogenetics - AGE @ Exeter","og_description":"Pharmacogenetics in cardiovascular prevention Inherited genetic variants can modify the effectiveness of medications, and contribute to inter-individual variability and susceptibility to side-effects. We provide much-needed observational evidence for the effect of pharmacogenetic variants on commonly-prescribed preventative medications for cardiovascular disease, especially statins (prescribed to reduce cholesterol), antihypertensives (prescribed to reduce blood pressure), and antiplatelets (prescribed [&hellip;]","og_url":"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/","og_site_name":"AGE @ Exeter","article_modified_time":"2024-09-25T12:04:52+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/","url":"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/","name":"Pharmacogenetics - AGE @ Exeter","isPartOf":{"@id":"https:\/\/sites.exeter.ac.uk\/age\/#website"},"datePublished":"2024-09-25T12:04:51+00:00","dateModified":"2024-09-25T12:04:52+00:00","breadcrumb":{"@id":"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/sites.exeter.ac.uk\/age\/research\/pharmacogenetics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sites.exeter.ac.uk\/age\/"},{"@type":"ListItem","position":2,"name":"Research","item":"https:\/\/sites.exeter.ac.uk\/age\/research\/"},{"@type":"ListItem","position":3,"name":"Pharmacogenetics"}]},{"@type":"WebSite","@id":"https:\/\/sites.exeter.ac.uk\/age\/#website","url":"https:\/\/sites.exeter.ac.uk\/age\/","name":"AGE @ Exeter","description":"Ageing and long-term conditions, Genetics, and Epidemiology group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sites.exeter.ac.uk\/age\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/pages\/321"}],"collection":[{"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/users\/293"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/comments?post=321"}],"version-history":[{"count":1,"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/pages\/321\/revisions"}],"predecessor-version":[{"id":323,"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/pages\/321\/revisions\/323"}],"up":[{"embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/pages\/159"}],"wp:attachment":[{"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/media?parent=321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/categories?post=321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/age\/wp-json\/wp\/v2\/tags?post=321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}